COVID-19 Impact on Global Pharmerging Market Size, Status and Forecast 2020-2026

September 2020 | 129 pages | ID: C0B678C6A106EN
QYResearch

Abstracts

This report focuses on the global Pharmerging status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmerging development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Pfizer
• Sanofi
• GlaxoSmithKline
• AstraZeneca
• Novartis
• Johnson & Johnson
• F. Hoffmann-La Roche
• Eli Lilly
• Boehringer Ingelheim
• Novo Nordisk
• AbbVie
• Sun Pharmaceutical
• Teva Pharmaceutical Industries
• Mitsubishi Tanabe Pharma
• Bristol-Myers Squibb
• Kyowa Hakko Kirin
• CSL Behring
• Takeda
• Amgen
• Bayer
• Biogen
• Eisai
• Daiichi Sankyo
• Dainippon Sumitomo Pharma

Market segment by Type, the product can be split into

• Tier 1
• Tier 2
• Tier 3

Market segment by Application, split into

• Lung Cancer
• Breast Cancer
• Chronic Myeloid Leukemia
• Lymphomas
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Pharmerging status, future forecast, growth opportunity, key market and key players.
• To present the Pharmerging development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Pharmerging are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmerging Revenue
1.4 Market Analysis by Type
  1.4.1 Global Pharmerging Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Tier
  1.4.3 Tier
  1.4.4 Tier
1.5 Market by Application
  1.5.1 Global Pharmerging Market Share by Application: 2020 VS 2026
  1.5.2 Lung Cancer
  1.5.3 Breast Cancer
  1.5.4 Chronic Myeloid Leukemia
  1.5.5 Lymphomas
  1.5.6 Other
1.6 Coronavirus Disease 2019 (Covid-19): Pharmerging Industry Impact
  1.6.1 How the Covid-19 is Affecting the Pharmerging Industry
    1.6.1.1 Pharmerging Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Pharmerging Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Pharmerging Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Pharmerging Market Perspective (2015-2026)
2.2 Pharmerging Growth Trends by Regions
  2.2.1 Pharmerging Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Pharmerging Historic Market Share by Regions (2015-2020)
  2.2.3 Pharmerging Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Pharmerging Market Growth Strategy
  2.3.6 Primary Interviews with Key Pharmerging Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Pharmerging Players by Market Size
  3.1.1 Global Top Pharmerging Players by Revenue (2015-2020)
  3.1.2 Global Pharmerging Revenue Market Share by Players (2015-2020)
  3.1.3 Global Pharmerging Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pharmerging Market Concentration Ratio
  3.2.1 Global Pharmerging Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Pharmerging Revenue in 2019
3.3 Pharmerging Key Players Head office and Area Served
3.4 Key Players Pharmerging Product Solution and Service
3.5 Date of Enter into Pharmerging Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Pharmerging Historic Market Size by Type (2015-2020)
4.2 Global Pharmerging Forecasted Market Size by Type (2021-2026)

5 PHARMERGING BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Pharmerging Market Size by Application (2015-2020)
5.2 Global Pharmerging Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Pharmerging Market Size (2015-2020)
6.2 Pharmerging Key Players in North America (2019-2020)
6.3 North America Pharmerging Market Size by Type (2015-2020)
6.4 North America Pharmerging Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Pharmerging Market Size (2015-2020)
7.2 Pharmerging Key Players in Europe (2019-2020)
7.3 Europe Pharmerging Market Size by Type (2015-2020)
7.4 Europe Pharmerging Market Size by Application (2015-2020)

8 CHINA

8.1 China Pharmerging Market Size (2015-2020)
8.2 Pharmerging Key Players in China (2019-2020)
8.3 China Pharmerging Market Size by Type (2015-2020)
8.4 China Pharmerging Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Pharmerging Market Size (2015-2020)
9.2 Pharmerging Key Players in Japan (2019-2020)
9.3 Japan Pharmerging Market Size by Type (2015-2020)
9.4 Japan Pharmerging Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Pharmerging Market Size (2015-2020)
10.2 Pharmerging Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pharmerging Market Size by Type (2015-2020)
10.4 Southeast Asia Pharmerging Market Size by Application (2015-2020)

11 INDIA

11.1 India Pharmerging Market Size (2015-2020)
11.2 Pharmerging Key Players in India (2019-2020)
11.3 India Pharmerging Market Size by Type (2015-2020)
11.4 India Pharmerging Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Pharmerging Market Size (2015-2020)
12.2 Pharmerging Key Players in Central & South America (2019-2020)
12.3 Central & South America Pharmerging Market Size by Type (2015-2020)
12.4 Central & South America Pharmerging Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Pharmerging Introduction
  13.1.4 Pfizer Revenue in Pharmerging Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 Sanofi
  13.2.1 Sanofi Company Details
  13.2.2 Sanofi Business Overview and Its Total Revenue
  13.2.3 Sanofi Pharmerging Introduction
  13.2.4 Sanofi Revenue in Pharmerging Business (2015-2020)
  13.2.5 Sanofi Recent Development
13.3 GlaxoSmithKline
  13.3.1 GlaxoSmithKline Company Details
  13.3.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.3.3 GlaxoSmithKline Pharmerging Introduction
  13.3.4 GlaxoSmithKline Revenue in Pharmerging Business (2015-2020)
  13.3.5 GlaxoSmithKline Recent Development
13.4 AstraZeneca
  13.4.1 AstraZeneca Company Details
  13.4.2 AstraZeneca Business Overview and Its Total Revenue
  13.4.3 AstraZeneca Pharmerging Introduction
  13.4.4 AstraZeneca Revenue in Pharmerging Business (2015-2020)
  13.4.5 AstraZeneca Recent Development
13.5 Novartis
  13.5.1 Novartis Company Details
  13.5.2 Novartis Business Overview and Its Total Revenue
  13.5.3 Novartis Pharmerging Introduction
  13.5.4 Novartis Revenue in Pharmerging Business (2015-2020)
  13.5.5 Novartis Recent Development
13.6 Johnson & Johnson
  13.6.1 Johnson & Johnson Company Details
  13.6.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.6.3 Johnson & Johnson Pharmerging Introduction
  13.6.4 Johnson & Johnson Revenue in Pharmerging Business (2015-2020)
  13.6.5 Johnson & Johnson Recent Development
13.7 F. Hoffmann-La Roche
  13.7.1 F. Hoffmann-La Roche Company Details
  13.7.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
  13.7.3 F. Hoffmann-La Roche Pharmerging Introduction
  13.7.4 F. Hoffmann-La Roche Revenue in Pharmerging Business (2015-2020)
  13.7.5 F. Hoffmann-La Roche Recent Development
13.8 Eli Lilly
  13.8.1 Eli Lilly Company Details
  13.8.2 Eli Lilly Business Overview and Its Total Revenue
  13.8.3 Eli Lilly Pharmerging Introduction
  13.8.4 Eli Lilly Revenue in Pharmerging Business (2015-2020)
  13.8.5 Eli Lilly Recent Development
13.9 Boehringer Ingelheim
  13.9.1 Boehringer Ingelheim Company Details
  13.9.2 Boehringer Ingelheim Business Overview and Its Total Revenue
  13.9.3 Boehringer Ingelheim Pharmerging Introduction
  13.9.4 Boehringer Ingelheim Revenue in Pharmerging Business (2015-2020)
  13.9.5 Boehringer Ingelheim Recent Development
13.10 Novo Nordisk
  13.10.1 Novo Nordisk Company Details
  13.10.2 Novo Nordisk Business Overview and Its Total Revenue
  13.10.3 Novo Nordisk Pharmerging Introduction
  13.10.4 Novo Nordisk Revenue in Pharmerging Business (2015-2020)
  13.10.5 Novo Nordisk Recent Development
13.11 AbbVie
  10.11.1 AbbVie Company Details
  10.11.2 AbbVie Business Overview and Its Total Revenue
  10.11.3 AbbVie Pharmerging Introduction
  10.11.4 AbbVie Revenue in Pharmerging Business (2015-2020)
  10.11.5 AbbVie Recent Development
13.12 Sun Pharmaceutical
  10.12.1 Sun Pharmaceutical Company Details
  10.12.2 Sun Pharmaceutical Business Overview and Its Total Revenue
  10.12.3 Sun Pharmaceutical Pharmerging Introduction
  10.12.4 Sun Pharmaceutical Revenue in Pharmerging Business (2015-2020)
  10.12.5 Sun Pharmaceutical Recent Development
13.13 Teva Pharmaceutical Industries
  10.13.1 Teva Pharmaceutical Industries Company Details
  10.13.2 Teva Pharmaceutical Industries Business Overview and Its Total Revenue
  10.13.3 Teva Pharmaceutical Industries Pharmerging Introduction
  10.13.4 Teva Pharmaceutical Industries Revenue in Pharmerging Business (2015-2020)
  10.13.5 Teva Pharmaceutical Industries Recent Development
13.14 Mitsubishi Tanabe Pharma
  10.14.1 Mitsubishi Tanabe Pharma Company Details
  10.14.2 Mitsubishi Tanabe Pharma Business Overview and Its Total Revenue
  10.14.3 Mitsubishi Tanabe Pharma Pharmerging Introduction
  10.14.4 Mitsubishi Tanabe Pharma Revenue in Pharmerging Business (2015-2020)
  10.14.5 Mitsubishi Tanabe Pharma Recent Development
13.15 Bristol-Myers Squibb
  10.15.1 Bristol-Myers Squibb Company Details
  10.15.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  10.15.3 Bristol-Myers Squibb Pharmerging Introduction
  10.15.4 Bristol-Myers Squibb Revenue in Pharmerging Business (2015-2020)
  10.15.5 Bristol-Myers Squibb Recent Development
13.16 Kyowa Hakko Kirin
  10.16.1 Kyowa Hakko Kirin Company Details
  10.16.2 Kyowa Hakko Kirin Business Overview and Its Total Revenue
  10.16.3 Kyowa Hakko Kirin Pharmerging Introduction
  10.16.4 Kyowa Hakko Kirin Revenue in Pharmerging Business (2015-2020)
  10.16.5 Kyowa Hakko Kirin Recent Development
13.17 CSL Behring
  10.17.1 CSL Behring Company Details
  10.17.2 CSL Behring Business Overview and Its Total Revenue
  10.17.3 CSL Behring Pharmerging Introduction
  10.17.4 CSL Behring Revenue in Pharmerging Business (2015-2020)
  10.17.5 CSL Behring Recent Development
13.18 Takeda
  10.18.1 Takeda Company Details
  10.18.2 Takeda Business Overview and Its Total Revenue
  10.18.3 Takeda Pharmerging Introduction
  10.18.4 Takeda Revenue in Pharmerging Business (2015-2020)
  10.18.5 Takeda Recent Development
13.19 Amgen
  10.19.1 Amgen Company Details
  10.19.2 Amgen Business Overview and Its Total Revenue
  10.19.3 Amgen Pharmerging Introduction
  10.19.4 Amgen Revenue in Pharmerging Business (2015-2020)
  10.19.5 Amgen Recent Development
13.20 Bayer
  10.20.1 Bayer Company Details
  10.20.2 Bayer Business Overview and Its Total Revenue
  10.20.3 Bayer Pharmerging Introduction
  10.20.4 Bayer Revenue in Pharmerging Business (2015-2020)
  10.20.5 Bayer Recent Development
13.21 Biogen
  10.21.1 Biogen Company Details
  10.21.2 Biogen Business Overview and Its Total Revenue
  10.21.3 Biogen Pharmerging Introduction
  10.21.4 Biogen Revenue in Pharmerging Business (2015-2020)
  10.21.5 Biogen Recent Development
13.22 Eisai
  10.22.1 Eisai Company Details
  10.22.2 Eisai Business Overview and Its Total Revenue
  10.22.3 Eisai Pharmerging Introduction
  10.22.4 Eisai Revenue in Pharmerging Business (2015-2020)
  10.22.5 Eisai Recent Development
13.23 Daiichi Sankyo
  10.23.1 Daiichi Sankyo Company Details
  10.23.2 Daiichi Sankyo Business Overview and Its Total Revenue
  10.23.3 Daiichi Sankyo Pharmerging Introduction
  10.23.4 Daiichi Sankyo Revenue in Pharmerging Business (2015-2020)
  10.23.5 Daiichi Sankyo Recent Development
13.24 Dainippon Sumitomo Pharma
  10.24.1 Dainippon Sumitomo Pharma Company Details
  10.24.2 Dainippon Sumitomo Pharma Business Overview and Its Total Revenue
  10.24.3 Dainippon Sumitomo Pharma Pharmerging Introduction
  10.24.4 Dainippon Sumitomo Pharma Revenue in Pharmerging Business (2015-2020)
  10.24.5 Dainippon Sumitomo Pharma Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Pharmerging Key Market Segments
Table 2. Key Players Covered: Ranking by Pharmerging Revenue
Table 3. Ranking of Global Top Pharmerging Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pharmerging Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Tier 1
Table 6. Key Players of Tier 2
Table 7. Key Players of Tier 3
Table 8. COVID-19 Impact Global Market: (Four Pharmerging Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Pharmerging Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Pharmerging Players to Combat Covid-19 Impact
Table 13. Global Pharmerging Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Pharmerging Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Pharmerging Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Pharmerging Market Share by Regions (2015-2020)
Table 17. Global Pharmerging Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Pharmerging Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Pharmerging Market Growth Strategy
Table 23. Main Points Interviewed from Key Pharmerging Players
Table 24. Global Pharmerging Revenue by Players (2015-2020) (Million US$)
Table 25. Global Pharmerging Market Share by Players (2015-2020)
Table 26. Global Top Pharmerging Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmerging as of 2019)
Table 27. Global Pharmerging by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Pharmerging Product Solution and Service
Table 30. Date of Enter into Pharmerging Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Pharmerging Market Size by Type (2015-2020) (Million US$)
Table 33. Global Pharmerging Market Size Share by Type (2015-2020)
Table 34. Global Pharmerging Revenue Market Share by Type (2021-2026)
Table 35. Global Pharmerging Market Size Share by Application (2015-2020)
Table 36. Global Pharmerging Market Size by Application (2015-2020) (Million US$)
Table 37. Global Pharmerging Market Size Share by Application (2021-2026)
Table 38. North America Key Players Pharmerging Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Pharmerging Market Share (2019-2020)
Table 40. North America Pharmerging Market Size by Type (2015-2020) (Million US$)
Table 41. North America Pharmerging Market Share by Type (2015-2020)
Table 42. North America Pharmerging Market Size by Application (2015-2020) (Million US$)
Table 43. North America Pharmerging Market Share by Application (2015-2020)
Table 44. Europe Key Players Pharmerging Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Pharmerging Market Share (2019-2020)
Table 46. Europe Pharmerging Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Pharmerging Market Share by Type (2015-2020)
Table 48. Europe Pharmerging Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Pharmerging Market Share by Application (2015-2020)
Table 50. China Key Players Pharmerging Revenue (2019-2020) (Million US$)
Table 51. China Key Players Pharmerging Market Share (2019-2020)
Table 52. China Pharmerging Market Size by Type (2015-2020) (Million US$)
Table 53. China Pharmerging Market Share by Type (2015-2020)
Table 54. China Pharmerging Market Size by Application (2015-2020) (Million US$)
Table 55. China Pharmerging Market Share by Application (2015-2020)
Table 56. Japan Key Players Pharmerging Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Pharmerging Market Share (2019-2020)
Table 58. Japan Pharmerging Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Pharmerging Market Share by Type (2015-2020)
Table 60. Japan Pharmerging Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Pharmerging Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Pharmerging Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Pharmerging Market Share (2019-2020)
Table 64. Southeast Asia Pharmerging Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Pharmerging Market Share by Type (2015-2020)
Table 66. Southeast Asia Pharmerging Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Pharmerging Market Share by Application (2015-2020)
Table 68. India Key Players Pharmerging Revenue (2019-2020) (Million US$)
Table 69. India Key Players Pharmerging Market Share (2019-2020)
Table 70. India Pharmerging Market Size by Type (2015-2020) (Million US$)
Table 71. India Pharmerging Market Share by Type (2015-2020)
Table 72. India Pharmerging Market Size by Application (2015-2020) (Million US$)
Table 73. India Pharmerging Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Pharmerging Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Pharmerging Market Share (2019-2020)
Table 76. Central & South America Pharmerging Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Pharmerging Market Share by Type (2015-2020)
Table 78. Central & South America Pharmerging Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Pharmerging Market Share by Application (2015-2020)
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Product
Table 83. Pfizer Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 84. Pfizer Recent Development
Table 85. Sanofi Company Details
Table 86. Sanofi Business Overview
Table 87. Sanofi Product
Table 88. Sanofi Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 89. Sanofi Recent Development
Table 90. GlaxoSmithKline Company Details
Table 91. GlaxoSmithKline Business Overview
Table 92. GlaxoSmithKline Product
Table 93. GlaxoSmithKline Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 94. GlaxoSmithKline Recent Development
Table 95. AstraZeneca Company Details
Table 96. AstraZeneca Business Overview
Table 97. AstraZeneca Product
Table 98. AstraZeneca Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 99. AstraZeneca Recent Development
Table 100. Novartis Company Details
Table 101. Novartis Business Overview
Table 102. Novartis Product
Table 103. Novartis Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 104. Novartis Recent Development
Table 105. Johnson & Johnson Company Details
Table 106. Johnson & Johnson Business Overview
Table 107. Johnson & Johnson Product
Table 108. Johnson & Johnson Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 109. Johnson & Johnson Recent Development
Table 110. F. Hoffmann-La Roche Company Details
Table 111. F. Hoffmann-La Roche Business Overview
Table 112. F. Hoffmann-La Roche Product
Table 113. F. Hoffmann-La Roche Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 114. F. Hoffmann-La Roche Recent Development
Table 115. Eli Lilly Business Overview
Table 116. Eli Lilly Product
Table 117. Eli Lilly Company Details
Table 118. Eli Lilly Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 119. Eli Lilly Recent Development
Table 120. Boehringer Ingelheim Company Details
Table 121. Boehringer Ingelheim Business Overview
Table 122. Boehringer Ingelheim Product
Table 123. Boehringer Ingelheim Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 124. Boehringer Ingelheim Recent Development
Table 125. Novo Nordisk Company Details
Table 126. Novo Nordisk Business Overview
Table 127. Novo Nordisk Product
Table 128. Novo Nordisk Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 129. Novo Nordisk Recent Development
Table 130. AbbVie Company Details
Table 131. AbbVie Business Overview
Table 132. AbbVie Product
Table 133. AbbVie Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 134. AbbVie Recent Development
Table 135. Sun Pharmaceutical Company Details
Table 136. Sun Pharmaceutical Business Overview
Table 137. Sun Pharmaceutical Product
Table 138. Sun Pharmaceutical Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 139. Sun Pharmaceutical Recent Development
Table 140. Teva Pharmaceutical Industries Company Details
Table 141. Teva Pharmaceutical Industries Business Overview
Table 142. Teva Pharmaceutical Industries Product
Table 143. Teva Pharmaceutical Industries Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 144. Teva Pharmaceutical Industries Recent Development
Table 145. Mitsubishi Tanabe Pharma Company Details
Table 146. Mitsubishi Tanabe Pharma Business Overview
Table 147. Mitsubishi Tanabe Pharma Product
Table 148. Mitsubishi Tanabe Pharma Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 149. Mitsubishi Tanabe Pharma Recent Development
Table 150. Bristol-Myers Squibb Company Details
Table 151. Bristol-Myers Squibb Business Overview
Table 152. Bristol-Myers Squibb Product
Table 153. Bristol-Myers Squibb Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 154. Bristol-Myers Squibb Recent Development
Table 155. Kyowa Hakko Kirin Company Details
Table 156. Kyowa Hakko Kirin Business Overview
Table 157. Kyowa Hakko Kirin Product
Table 158. Kyowa Hakko Kirin Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 159. Kyowa Hakko Kirin Recent Development
Table 160. CSL Behring Company Details
Table 161. CSL Behring Business Overview
Table 162. CSL Behring Product
Table 163. CSL Behring Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 164. CSL Behring Recent Development
Table 165. Takeda Company Details
Table 166. Takeda Business Overview
Table 167. Takeda Product
Table 168. Takeda Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 169. Takeda Recent Development
Table 170. Amgen Company Details
Table 171. Amgen Business Overview
Table 172. Amgen Product
Table 173. Amgen Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 174. Amgen Recent Development
Table 175. Bayer Company Details
Table 176. Bayer Business Overview
Table 177. Bayer Product
Table 178. Bayer Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 179. Bayer Recent Development
Table 180. Biogen Company Details
Table 181. Biogen Business Overview
Table 182. Biogen Product
Table 183. Biogen Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 184. Biogen Recent Development
Table 185. Eisai Company Details
Table 186. Eisai Business Overview
Table 187. Eisai Product
Table 188. Eisai Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 189. Eisai Recent Development
Table 190. Daiichi Sankyo Company Details
Table 191. Daiichi Sankyo Business Overview
Table 192. Daiichi Sankyo Product
Table 193. Daiichi Sankyo Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 194. Daiichi Sankyo Recent Development
Table 195. Dainippon Sumitomo Pharma Company Details
Table 196. Dainippon Sumitomo Pharma Business Overview
Table 197. Dainippon Sumitomo Pharma Product
Table 198. Dainippon Sumitomo Pharma Revenue in Pharmerging Business (2015-2020) (Million US$)
Table 199. Dainippon Sumitomo Pharma Recent Development
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Pharmerging Market Share by Type: 2020 VS 2026
Figure 2. Tier 1 Features
Figure 3. Tier 2 Features
Figure 4. Tier 3 Features
Figure 5. Global Pharmerging Market Share by Application: 2020 VS 2026
Figure 6. Lung Cancer Case Studies
Figure 7. Breast Cancer Case Studies
Figure 8. Chronic Myeloid Leukemia Case Studies
Figure 9. Lymphomas Case Studies
Figure 10. Other Case Studies
Figure 11. Pharmerging Report Years Considered
Figure 12. Global Pharmerging Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Pharmerging Market Share by Regions: 2020 VS 2026
Figure 14. Global Pharmerging Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Pharmerging Market Share by Players in 2019
Figure 17. Global Top Pharmerging Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmerging as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Pharmerging Revenue in 2019
Figure 19. North America Pharmerging Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Pharmerging Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Pharmerging Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Pharmerging Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Pharmerging Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Pharmerging Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Pharmerging Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Pfizer Revenue Growth Rate in Pharmerging Business (2015-2020)
Figure 28. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Sanofi Revenue Growth Rate in Pharmerging Business (2015-2020)
Figure 30. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. GlaxoSmithKline Revenue Growth Rate in Pharmerging Business (2015-2020)
Figure 32. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. AstraZeneca Revenue Growth Rate in Pharmerging Business (2015-2020)
Figure 34. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Novartis Revenue Growth Rate in Pharmerging Business (2015-2020)
Figure 36. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Johnson & Johnson Revenue Growth Rate in Pharmerging Business (2015-2020)
Figure 38. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. F. Hoffmann-La Roche Revenue Growth Rate in Pharmerging Business (2015-2020)
Figure 40. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Eli Lilly Revenue Growth Rate in Pharmerging Business (2015-2020)
Figure 42. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Boehringer Ingelheim Revenue Growth Rate in Pharmerging Business (2015-2020)
Figure 44. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Novo Nordisk Revenue Growth Rate in Pharmerging Business (2015-2020)
Figure 46. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. AbbVie Revenue Growth Rate in Pharmerging Business (2015-2020)
Figure 48. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Sun Pharmaceutical Revenue Growth Rate in Pharmerging Business (2015-2020)
Figure 50. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Teva Pharmaceutical Industries Revenue Growth Rate in Pharmerging Business (2015-2020)
Figure 52. Mitsubishi Tanabe Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Mitsubishi Tanabe Pharma Revenue Growth Rate in Pharmerging Business (2015-2020)
Figure 54. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Bristol-Myers Squibb Revenue Growth Rate in Pharmerging Business (2015-2020)
Figure 56. Kyowa Hakko Kirin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Kyowa Hakko Kirin Revenue Growth Rate in Pharmerging Business (2015-2020)
Figure 58. CSL Behring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. CSL Behring Revenue Growth Rate in Pharmerging Business (2015-2020)
Figure 60. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Takeda Revenue Growth Rate in Pharmerging Business (2015-2020)
Figure 62. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Amgen Revenue Growth Rate in Pharmerging Business (2015-2020)
Figure 64. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Bayer Revenue Growth Rate in Pharmerging Business (2015-2020)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed